Skip to main content
. Author manuscript; available in PMC: 2015 Nov 10.
Published in final edited form as: J Clin Psychopharmacol. 2012 Oct;32(5):630–636. doi: 10.1097/JCP.0b013e3182676956

TABLE 1.

Baseline Demographic and Smoking Characteristics

Placebo
Naltrexone
Variable Men (n = 71) Women (n = 83) Men (n = 76) Women (n = 85)
Age, mean (SD), y 40.6* (11.0) 44.3 (10.0) 38.2* (11.3) 44.1 (12.0)
Education (years completed), mean (SD) 15.1 (1.7) 15.0 (2.7) 15.4 (2.6) 14.8 (2.8)
Hollingshead index, mean (SD) 46.4 (13.5) 46.6 (12.8) 46.3 (14.8) 45.6 (13.8)
Body mass index, mean (SD), kg/m2 26.7 (4.2) 27.1 (4.6) 26.9 (4.4) 27.3 (4.6)
Drinks per week in current drinkers,* mean (SD) 8.6 (9.3) 5.1 (9.1) 7.7 (7.8) 3.8 (3.7)
Cigarettes per day, mean (SD) 21.7 (7.6) 19.1 (5.5) 19.0 (5.2) 19.2 (5.5)
Age of smoking initiation, mean (SD) 15.0 (3.4) 14.8 (3.6) 15.2 (3.5) 15.2 (4.6)
Carbon monoxide level, mean (SD), ppm 24.8 (15.2) 24.0 (10.9) 23.0 (10.5) 21.3 (11.1)
Nicotine dependence (FTND), mean (SD) 5.5 (1.7) 5.3 (1.8) 4.8 (1.7) 5.3 (1.8)
Smoking urge (BQSU), mean (SD) 28.5 (11.8) 28.7 (11.4) 29.9 (9.9) 30.9 (11.6)
No. past quit attempts (>12 h), mean (SD) 4.4 (5.1) 3.8 (6.4) 5.5 (13.9) 3.8 (3.7)
Beck Depression Inventory, mean (SD) 4.7 (4.8) 4.1 (4.5) 3.6 (4.0) 3.4 (3.4)
Race, n (%)
    Caucasian 46 (64.8) 47 (56.6) 44 (57.9) 44 (51.8)
    African American 22 (31) 30 (36.2) 20 (26.3) 38 (44.7)
    Asian 1 (1.4) 1 (1.2) 5 (6.6) 1 (1.2)
    More than 1 race/other 2 (2.8) 5 (6) 7 (9.2) 2 (2.3)
Ethnicity (non-Hispanic), n (%) 67 (94.4) 80 (96.4) 73 (96.1) 83 (97.6)
Married or living with partner, n (%) 25 (35) 25 (33) 28 (34) 24 (28)
Sexual preference for opposite sex, n (%) 60 (85.7) 76 (91.6) 61 (81.3) 78 (91.8)
Current alcohol drinker, n (%) 60 (87) 71 (90) 69 (93) 72 (86)

Current alcohol drinker defined as consuming at least one drink in past six months.

*

Drinks per week were analyzed taking into account the participants’ body water estimates.

Sex difference, P < 0.05.

BQSU indicates Brief Questionnaire of Smoking Urges; FTND, Fagerström Test of Nicotine Dependence.